The withdrawal for multiple sclerosis progressed as announced today Monday (3.2.25). The medicine MIOREL TAB 10MG/TAB with EOF code 2268401, recalled by the EOF due to deviations in the effects on appearance, on control of fracture resistance and on vulnerability control. CORVERSE This Decision shall be adopted in the context of public health protection in order to strengthen the actions of the company “Provident PHARMACEUTICAL Ltd”. The company “PROVIDENT PHARMACEUTICAL Ltd” as K.A.K. must contact the recipients of the consignment, namely pharmacies and pharmaceutical stores, and withdraw them from the market within a reasonable period of time. The relevant documents shall be kept for a period of at least five years and shall be taken into account by the IF, if requested.
FDA’s recalling medication for multiple sclerosis
—
in Greece